Skip to content

Comparsion of intraincisional bupivacaine, tramadol and bupivacaine plus tramadol in postoperative pain in elective cesarean section patients

Comparsion of intraincisional bupivacaine, tramadol and bupivacaine plus tramadol in postoperative pain in elective cesarean section patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110306005993N3
Enrollment
90
Registered
2021-11-14
Start date
2021-08-19
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section pain control. Delivery by emergency caesarean section

Interventions

Intervention 1: Intervention group: The recipient of 100 mg of tramadol, which has reached a volume of 10 ml with normal saline, is finally injected by the surgeon at the incision site. Intervention 2

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age between 15-45 years Have informed written consent to cooperate with the study Patient classification in class ASA1,2

Exclusion criteria

Exclusion criteria: The patient refused to continue collaborating in this study Adequate spinal anesthesia and its conversion to general anesthesia Allergy to any of the drugs used History of addiction Existence of underlying pain such as back pain, headache History of using psychiatric drugs Get preoperative housing History of addiction

Design outcomes

Primary

MeasureTime frame
The amount of pain. Timepoint: Intervals 6, 12 and 24 hours after surgery. Method of measurement: The Visual Analogue Scale (VAS) consists of a pain ruler that includes a horizontal line that is graded from zero to 10, with a 0-1 sign of pain 2-3 mild pain 4-6 moderate pain and 7 or more It is a sign of severe pain. In addition, it has various visual forms to determine the severity of pain.

Secondary

MeasureTime frame
Nausea and vomiting. Timepoint: Intervals of 6, 12 and 24 hours. Method of measurement: Yes-no based on patient observations and statements.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Seyed Abdollah Emadi

Mazandaran University of Medical Sciences

aemadi@mazums.ac.ir+98 11 3336 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026